Skip to main
TRS

TriMas (TRS) Stock Forecast & Price Target

TriMas (TRS) Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

TriMas Corp has reported rising sales across its business segments, indicating a positive trajectory for both revenue and earnings growth expected in 2025, particularly driven by the packaging segment. The third quarter financial results surpassed estimates, with reported sales of $269.3 million exceeding the expected $260.1 million, highlighting strong demand in industrial and life sciences despite some challenges in the food and beverages category. Additionally, the company is focused on simplifying its operations and reducing corporate overhead, which may enhance operational efficiency and contribute to financial stability.

Bears say

TriMas Corp's recent appointment of a permanent CFO has led to a selloff in shares, indicating investor concerns regarding the completion of its strategic alternatives following the anticipated sale of its aerospace division. Given that the packaging segment is the primary revenue driver, any disruptions or uncertainties in this area could significantly impact overall financial performance. Additionally, the negative market reaction suggests a lack of confidence in the company's future growth trajectory, further contributing to a pessimistic outlook on its stock.

TriMas (TRS) has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of TriMas and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About TriMas (TRS) Forecast

Analysts have given TriMas (TRS) a Buy based on their latest research and market trends.

According to 2 analysts, TriMas (TRS) has a Buy consensus rating as of Apr 1, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $41.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $41.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

TriMas (TRS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.